Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta

Atherosclerosis

Volumn 179, Issue 1, 2005, Pages 27-33

  Turunen, Päivi ^a   Puhakka, Hanna ^a   Rutanen, Juha ^a   Hiltunen, Mikko O ^a   Heikura, Tommi ^a   Gruchala, Marcin ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adenovirus; Gene transfer; Lipoprotein associated phospholipase A2; Restenosis

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; LIPOPROTEIN; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; APOPTOSIS; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; TRANSGENE;

EID: 13844254235     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.10.025     Document Type: Article

References (35)

1. Bittl JA. Advances in coronary angioplasty [published erratum appears in N Engl J Med 1997 Feb 27;336(9):670]. N Engl J Med 1996;335:1290-302.
2. J.H. Ip, V. Fuster, and L. Badimon Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
3. P. Libby, D. Schwartz, E. Brogi, H. Tanaka, and S.K. Clinton A cascade model for restenosis. A special case of atherosclerosis progression Circulation 86 1992 III47 III52
4. J.D. Marmur, M. Poon, M. Rossikhina, and M.B. Taubman Induction of PDGF-responsive genes in vascular smooth muscle Implications for the early response to vessel injury Circulation 86 1992 III53 III60
5. H. Le Breton, E.F. Plow, and E.J. Topol Role of platelets in restenosis after percutaneous coronary revascularization J Am Coll Cardiol 28 1996 1643 1651
6. G.L. Stahl, Z. Terashita, and A.M. Lefer Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia J Pharmacol Exp Ther 244 1988 898 904
7. K.E. Stremler, D.M. Stafforini, S.M. Prescott, and T.M. McIntyre Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates J Biol Chem 266 1991 11095 11103
8. F.J. Neumann, I. Ott, M. Gawaz, G. Puchner, and A. Schomig Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty J Am Coll Cardiol 27 1996 819 824
9. M. Triggiani, R.P. Schleimer, J.A. Warner, and F.H. Chilton Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells J Immunol 147 1991 660 666
10. L.L. Stoll, and A.A. Spector Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture J Cell Physiol 139 1989 253 261
11. G.A. Zimmerman, T.M. McIntyre, S.M. Prescott, and D.M. Stafforini The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis Crit Care Med 30 2002 S294 S301
12. H.P. Souza, L.C. Souza, and V.M. Anastacio Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity Free Radic Biol Med 28 2000 1232 1242
13. J.C. Tardif, G. Cote, and J. Lesperance Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group N Engl J Med 337 1997 365 372
14. M.O. Laukkanen, A. Kivela, and T. Rissanen Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta Circulation 106 2002 1999 2003
15. D.G. Tew, C. Southan, and S.Q.J. Rice Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins Arteriosclerosis Thromb Vasc Biol 16 1996 591 599
16. M. Laitinen, K. Mäkinen, and H. Manninen Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia Hum Gene Ther 9 1998 1481 1486
17. P. Turunen, J. Jalkanen, and T. Heikura Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro J Lipid Res 45 2004 1633 1639
18. M.O. Hiltunen, M. Laitinen, and M.P. Turunen Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta Circulation 102 2000 2262 2268
19. M. Laitinen, J. Hartikainen, and M.O. Hiltunen Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty Hum Gene Ther 11 2000 263 270
20. O. Leppanen, J. Rutanen, and M.O. Hiltunen Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits Circulation 109 2004 1140 1146
21. J.K. Mickelson, N.M. Lakkis, G. Villarreal-Levy, B.J. Hughes, and C.W. Smith Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 28 1996 345 353
22. F.J. Neumann, I. Ott, M. Gawaz, G. Puchner, and A. Schomig Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty J Am Coll Cardiol 27 1996 819 824
23. L.L. Stoll, and A.A. Spector Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture J Cell Physiol 139 1989 253 261
24. J.M. Heery, M. Kozak, and D.M. Stafforini Oxidatively modified LDL contains phospholipids with platelet- activating factor-like activity and stimulates the growth of smooth muscle cells J Clin Invest 96 1995 2322 2330
25. Y. Ohara, T.E. Peterson, and D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91 1993 2546 2551
26. R. Quarck, B. De Geest, and D. Stengel Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice Circulation 103 2001 2495 2500
27. G. Theilmeier, G.B. De, and P.P. Van Veldhoven HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice FASEB J 14 2000 2032 2039
28. M. Eisaf, and A.D. Tselepis Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis Biochem Pharmacol 66 2003 2069 2073
29. C.H. Chen Platelet-activating factor acetylhydrolase: is it good or bad for you? Curr Opin Lipidol 15 2004 337 341
30. M.J. Caslake, C.J. Packard, and K.E. Suckling Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease Atherosclerosis 150 2000 413 419
31. K. Walsh, R.C. Smith, and H.S. Kim Vascular cell apoptosis in remodeling, restenosis, and plaque rupture Circ Res 87 3 2000 184 188
32. A. Matsuzawa, K. Hattori, J. Aoki, H. Arai, and K. Inoue Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II J Biol Chem 272 1997 32315 32320
33. T.W. Kuijpers, J.M. van den Berg, A.T. Tool, and D. Roos The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase Clin Exp Immunol 123 2001 412 420
34. C.H. Chen, T. Jiang, and J.H. Yang Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription Circulation 107 2003 2102 2108
35. Beohar N, Flaherty JD, Davidson CJ, et al. Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 2003;6;109(1):108-13.